AQ LabsClinical trial sample management

Every trial sample accounted for, from collection to reconciliation.

Sample management for NHS trusts, CRDC hubs and spokes, Phase 1 units, site networks and CROs. Collection supplies, processing, storage, shipments and laboratory follow-up are managed on one record, linked to study requirements, staff authorisation and the site file.

Laboratory query · six weeks after the visit
Was sample 301-014-W12-PK1 stored at −80 °C within 60 minutes?
Q-0112
Sample journey
Collected
Processed
Stored
Shipped
Analysed
Can the site answer?
Separate recordsFive systems, kept by hand
08:31Paper log
08:52Spreadsheet
No timeFreezer map
14:30Courier email
ReceivedLab portal
Cannot be evidencedStorage time was never recorded
With AQ Labs.One record, every step attributed
08:31A. Okafor
08:52J. Reid
09:20J. Reid
14:30L. Patel
Day 2Central lab
Answered in secondsStored 09:20 · 49 of 60 minutes
Supports ICH-GCP E6(R3) ALCOA+ 21 CFR Part 11 electronic signatures NHS DSPT UK-hosted
What AQ Labs is

AQ Labs is lab sample management software for clinical research sites. It records every trial sample from the sponsor’s lab manual through collection supplies, collection, processing, storage, shipment and laboratory queries to result review where the study requires it.

Every step attributed to a named person Records linked to the site file
Site file AQ Labs

Most sample management tools operate alongside the site file. AQ Labs operates within it.

Inside a study visit

From scheduled collection to documented outcome.

Two samples from the same visit, each followed through its own workflow.

301-014-W12-PK1 STD-64017Participant 301-014Week 12Dose recorded 08:50 Fictional data · settings and limits are study-specific
301-014 Sample scheduled
Recorded on the sample
SamplePK plasma, pre-dose
Tube4 mL K2EDTA
Window08:20–08:50
SuppliesReserved, in date
01

Scheduled.

The Week 12 visit is booked, so the sample is scheduled: PK plasma, pre-dose, within 30 minutes before the dose, 4 mL K2EDTA, two aliquots, to be placed at minus 80 °C within 60 minutes of collection. In-date collection supplies are reserved.

The sample and its timing are set from the lab manual.
Sample schedule · Week 12
SamplePK plasma, pre-doseSet
TimingWithin 30 min before the dose08:20–08:50
Tube4 mL K2EDTA · two aliquotsSet
Storage−80 °C within 60 min of collectionLimit
SuppliesIn date, reserved for this visitReserved
301-014-W12-PK1 STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Sample scheduled
Recorded on the sample
SamplePK plasma, pre-dose
Tube4 mL K2EDTA
Window08:20–08:50
SuppliesReserved, in date
01

Scheduled.

The Week 12 visit is booked, so the sample is scheduled: PK plasma, pre-dose, within 30 minutes before the dose, 4 mL K2EDTA, two aliquots, to be placed at minus 80 °C within 60 minutes of collection. In-date collection supplies are reserved.

The sample and its timing are set from the lab manual.
Sample schedule · Week 12
SamplePK plasma, pre-doseSet
TimingWithin 30 min before the dose08:20–08:50
Tube4 mL K2EDTA · two aliquotsSet
Storage−80 °C within 60 min of collectionLimit
SuppliesIn date, reserved for this visitReserved
301-014-W12-PK1 STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Sample scheduled
Recorded on the sample
SamplePK plasma, pre-dose
Tube4 mL K2EDTA
Window08:20–08:50
SuppliesReserved, in date
01

Scheduled.

The Week 12 visit is booked, so the sample is scheduled: PK plasma, pre-dose, within 30 minutes before the dose, 4 mL K2EDTA, two aliquots, to be placed at minus 80 °C within 60 minutes of collection. In-date collection supplies are reserved.

The sample and its timing are set from the lab manual.
Sample schedule · Week 12
SamplePK plasma, pre-doseSet
TimingWithin 30 min before the dose08:20–08:50
Tube4 mL K2EDTA · two aliquotsSet
Storage−80 °C within 60 min of collectionLimit
SuppliesIn date, reserved for this visitReserved
301-014-W12-PK1 STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Collected 08:31
Recorded on the sample
Collected08:31 (event time)
Entered08:33 (entry time)
Before dose19 minutes
CollectorAuthorised
02

Collected.

The nurse scans the supplies and participant label and records the collection time as 08:31, 19 minutes before the recorded dose. AQ Labs records the entry time separately and confirms that the collector is authorised for this study.

Scan both labels to record the collection.
Pre-dose windowScan to record collection
08:20 window opens08:50 dose
301-014-W12-PK1 STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Collected 08:31
Recorded on the sample
Collected08:31 (event time)
Entered08:33 (entry time)
Before dose19 minutes
CollectorAuthorised
02

Collected.

The nurse scans the supplies and participant label and records the collection time as 08:31, 19 minutes before the recorded dose. AQ Labs records the entry time separately and confirms that the collector is authorised for this study.

Scan both labels to record the collection.
Pre-dose window19 min before dose · within window
08:20 window opens08:31 collected08:50 dose
301-014-W12-PK1 STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Aliquots stored
Recorded on the sample
Aliquot 1F2 · box 4 · A1
Aliquot 2F2 · box 4 · A2
Stored09:20
Elapsed49 of 60 minutes
03

Processed and stored.

The sample is centrifuged as the lab manual specifies and divided into two aliquots, each with its own identifier. Aliquot 1 is placed in freezer F2, box 4, position A1 and aliquot 2 in position A2 at 09:20, 49 minutes after collection and within the study’s limit.

Complete each step against the study limit.
Collection to storage0of 60 min
CentrifugeNext
AliquotWaiting
StoreWaiting
Freezer F2 · box 4
Positions A1 and A2 reserved
301-014-W12-PK1 STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Aliquots stored
Recorded on the sample
Aliquot 1F2 · box 4 · A1
Aliquot 2F2 · box 4 · A2
Stored09:20
Elapsed49 of 60 minutes
03

Processed and stored.

The sample is centrifuged as the lab manual specifies and divided into two aliquots, each with its own identifier. Aliquot 1 is placed in freezer F2, box 4, position A1 and aliquot 2 in position A2 at 09:20, 49 minutes after collection and within the study’s limit.

Complete each step against the study limit.
Collection to storage49of 60 min
CentrifugeAs the lab manual specifies
AliquotTwo aliquots, own identifiers
StoreA1 and A2 · 09:20
Freezer F2 · box 4
Aliquots in A1 and A2 at 09:20
301-014-W12-PK1 STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Shipped, frozen
Recorded on the sample
ShipmentFrozen, central lab
ManifestLinked to site file
ReceiptAwaiting
AnalysisPer aliquot
04

Shipped and received.

Both aliquots are scanned into a frozen shipment to the central laboratory, with the manifest linked to the site file. Laboratory receipt and analysis status are recorded against each aliquot.

Record laboratory receipt against each aliquot.
Frozen shipment · central laboratory
Aliquot 1301-014-W12-PK1-A1In transit
Aliquot 2301-014-W12-PK1-A2In transit
ManifestM-0412 · linked to the site fileLinked
AnalysisAwaiting receiptWaiting
301-014-W12-PK1 STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Received by laboratory
Recorded on the sample
ShipmentFrozen, central lab
ManifestLinked to site file
ReceiptRecorded
AnalysisPer aliquot
04

Shipped and received.

Both aliquots are scanned into a frozen shipment to the central laboratory, with the manifest linked to the site file. Laboratory receipt and analysis status are recorded against each aliquot.

Record laboratory receipt against each aliquot.
Frozen shipment · central laboratory
Aliquot 1301-014-W12-PK1-A1Received
Aliquot 2301-014-W12-PK1-A2Received
ManifestM-0412 · linked to the site fileLinked
AnalysisStatus recorded per aliquotPending
301-014-W12-SB STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Requested
Recorded on the sample
SampleSafety bloods
LaboratoryLocal NHS
RequestLab identifiers
VisitWeek 12
01

Requested.

Safety bloods due at Week 12 are listed with the visit and requested from the local laboratory using its identification requirements.

The request follows the receiving laboratory’s requirements.
Local laboratory request · Week 12
VisitWeek 12 · safety bloods dueListed
LaboratoryLocal NHS laboratoryReceiving
IdentificationAs the receiving laboratory requiresApplied
RequestRaised with the visitSent
301-014-W12-SB STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Requested
Recorded on the sample
SampleSafety bloods
LaboratoryLocal NHS
RequestLab identifiers
VisitWeek 12
01

Requested.

Safety bloods due at Week 12 are listed with the visit and requested from the local laboratory using its identification requirements.

The request follows the receiving laboratory’s requirements.
Local laboratory request · Week 12
VisitWeek 12 · safety bloods dueListed
LaboratoryLocal NHS laboratoryReceiving
IdentificationAs the receiving laboratory requiresApplied
RequestRaised with the visitSent
301-014-W12-SB STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Sent to laboratory
Recorded on the sample
Collected09:05
Handed over09:40
DestinationLocal laboratory
StatusSent
02

Collected and sent.

Collection time and handover to the laboratory are recorded.

Collection and handover are each recorded.
Collection and handover
Collected09:05Recorded
CollectorAuthorised for this studyPass
Handed over09:40 to the local laboratoryRecorded
301-014-W12-SB STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Sent to laboratory
Recorded on the sample
Collected09:05
Handed over09:40
DestinationLocal laboratory
StatusSent
02

Collected and sent.

Collection time and handover to the laboratory are recorded.

Collection and handover are each recorded.
Collection and handover
Collected09:05Recorded
CollectorAuthorised for this studyPass
Handed over09:40 to the local laboratoryRecorded
301-014-W12-SB STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Result recorded
Recorded on the sample
ResultRecorded
Out of range2 values
SourceLocal laboratory
StatusAwaiting review
03

Result recorded.

The result is recorded against the sample, and out-of-range values are highlighted.

Out-of-range values are highlighted for review.
Local laboratory result · Week 12
ALT68 U/L · range 7–56Out of range
Haemoglobin128 g/L · range 120–160In range
Potassium5.6 mmol/L · range 3.5–5.3Out of range
Creatinine82 µmol/L · range 60–110In range
301-014-W12-SB STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Result recorded
Recorded on the sample
ResultRecorded
Out of range2 values
SourceLocal laboratory
StatusAwaiting review
03

Result recorded.

The result is recorded against the sample, and out-of-range values are highlighted.

Out-of-range values are highlighted for review.
Local laboratory result · Week 12
ALT68 U/L · range 7–56Out of range
Haemoglobin128 g/L · range 120–160In range
Potassium5.6 mmol/L · range 3.5–5.3Out of range
Creatinine82 µmol/L · range 60–110In range
301-014-W12-SB STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Awaiting review
Recorded on the sample
ReviewInvestigator
AssessmentPer value
SignatureRe-authenticated
LinkedParticipant record
04

Reviewed.

The investigator records whether each out-of-range value is clinically significant and signs with re-authentication. The signed review is linked to the participant’s record.

Record an assessment for each out-of-range value, then sign.
Local laboratory result · Week 122 to judge
ALT68 U/L · range 7–56
Haemoglobin128 g/L · range 120–160 In range
Potassium5.6 mmol/L · range 3.5–5.3
Creatinine82 µmol/L · range 60–110 In range
301-014-W12-SB STD-64017Participant 301-014Week 12Dose recorded 08:50Fictional data · settings and limits are study-specific
301-014 Review signed
Recorded on the sample
ReviewInvestigator
AssessmentPer value
SignatureRe-authenticated
LinkedParticipant record
04

Reviewed.

The investigator records whether each out-of-range value is clinically significant and signs with re-authentication. The signed review is linked to the participant’s record.

Record an assessment for each out-of-range value, then sign.
Local laboratory result · Week 12Signed
ALT68 U/L · range 7–56
Haemoglobin128 g/L · range 120–160 In range
Potassium5.6 mmol/L · range 3.5–5.3
Creatinine82 µmol/L · range 60–110 In range
Everything in one view

How does AQ Labs simplify sample tracking?

It replaces separately maintained trackers with one view of collection supplies, samples and outstanding actions across every study and laboratory.

Visits and samples due, supplies to check, shipments to pack and results awaiting review. TUE 14 OCT
2
Visits
9
Samples due
2
Shipments
3
To review
08:30 · Supply check
Week 12 collection supplies
Supplies reserved against booked visits
All in date
Reorder not needed
STD-64017 · lot K-2291 · in date to 30 Nov
08:30 · Supply check
Week 12 collection supplies
Supplies reserved against booked visits
All in date
Reorder not needed
STD-64017 · lot K-2291 · in date to 30 Nov
09:00 · Visit
Participant 301-014 · Week 12
Samples listed in order of draw
Authorised collector on the rota
Collection supplies reserved, in date
STD-64017 · PK plasma ×2, safety bloods
10:30 · Visit
Participant 204-007 · Day 28
Request ready for the hospital laboratory
Collector authorised
Result to be recorded and signed
STD-71102 · FBC, U&E to local laboratory
13:00 · To review
Central lab report · 301-009 Week 8
Values highlighted for the investigator
Clinical significance to be recorded
Re-authentication at signature
STD-64017 · 2 out-of-range values
14:30 · Shipment
Frozen shipment to central lab
Stability and ship-day checks passed
UN3373 and dry ice checklist
Manifest files on collection
STD-58820 · 18 aliquots · dry ice
15:00 · Shipment
Courier collection
Courier confirmed for today
Samples scanned into the shipment
Handover recorded
Same-day ambient samples
Tomorrow3 visits ready: supplies, collector and courier confirmed
Visits and samples due, supplies to check, shipments to pack and results awaiting review. TUE 14 OCT
2
Visits
9
Samples due
2
Shipments
3
To review
08:30 · Supply check
Week 12 collection supplies
Supplies reserved against booked visits
All in date
Reorder not needed
STD-64017 · lot K-2291 · in date to 30 Nov
08:30 · Supply check
Week 12 collection supplies
Supplies reserved against booked visits
All in date
Reorder not needed
STD-64017 · lot K-2291 · in date to 30 Nov
09:00 · Visit
Participant 301-014 · Week 12
Samples listed in order of draw
Authorised collector on the rota
Collection supplies reserved, in date
STD-64017 · PK plasma ×2, safety bloods
10:30 · Visit
Participant 204-007 · Day 28
Request ready for the hospital laboratory
Collector authorised
Result to be recorded and signed
STD-71102 · FBC, U&E to local laboratory
13:00 · To review
Central lab report · 301-009 Week 8
Values highlighted for the investigator
Clinical significance to be recorded
Re-authentication at signature
STD-64017 · 2 out-of-range values
14:30 · Shipment
Frozen shipment to central lab
Stability and ship-day checks passed
UN3373 and dry ice checklist
Manifest files on collection
STD-58820 · 18 aliquots · dry ice
15:00 · Shipment
Courier collection
Courier confirmed for today
Samples scanned into the shipment
Handover recorded
Same-day ambient samples
Tomorrow3 visits ready: supplies, collector and courier confirmed
The current status and location of any sample, found by scanning its label or searching by participant, study or site. SCAN · 301-014-W12-PK1
301-014-W12-PK1PK plasma · Week 12
Try another:
Manifest
M-0412, filed on collection
Handover
14:30 to the courier
Pack
Dry ice · UN3373 checklist complete
301-014-W12-PK1PK plasma · Week 12
Try another:
Who
A. Okafor, research nurse
When
09:06, stamped at the scan
Where
Clinic room 2
301-014-W12-PK1PK plasma · Week 12
Try another:
Who
J. Reid, laboratory technician
When
09:31 · 1,500 g · 10 min · 4 °C
Where
Processing lab, centrifuge C1
301-014-W12-PK1PK plasma · Week 12
Try another:
Who
J. Reid
When
09:58, 52 minutes after collection
Where
Freezer F2 · box 4 · A1 · −80 °C
301-014-W12-PK1PK plasma · Week 12
Try another:
Manifest
M-0412, filed on collection
Handover
14:30 to the courier
Pack
Dry ice · UN3373 checklist complete
301-014-W12-PK1PK plasma · Week 12
Try another:
Laboratory
Central laboratory
Analysis
Status recorded per aliquot
Site file
Manifest linked
204-007-D28-FBCFBC · local laboratory
Try another:
Who
A. Okafor, research nurse
When
09:06, stamped at the scan
Where
Clinic room 2
204-007-D28-FBCFBC · local laboratory
Try another:
Who
J. Reid, laboratory technician
When
09:31 · 1,500 g · 10 min · 4 °C
Where
Processing lab, centrifuge C1
204-007-D28-FBCFBC · local laboratory
Try another:
Who
J. Reid
When
09:58, 52 minutes after collection
Where
Freezer F2 · box 4 · A1 · −80 °C
204-007-D28-FBCFBC · local laboratory
Try another:
Manifest
M-0412, filed on collection
Handover
14:30 to the courier
Pack
Dry ice · UN3373 checklist complete
204-007-D28-FBCFBC · local laboratory
Try another:
Laboratory
Central laboratory
Analysis
Status recorded per aliquot
Site file
Manifest linked
301-011-W4-SERSerum · on hold
Try another:
Who
A. Okafor, research nurse
When
09:06, stamped at the scan
Where
Clinic room 2
301-011-W4-SERSerum · on hold
Try another:
Who
J. Reid, laboratory technician
When
09:31 · 1,500 g · 10 min · 4 °C
Where
Processing lab, centrifuge C1
301-011-W4-SERSerum · on hold
Try another:
Who
J. Reid
When
09:58, 52 minutes after collection
Where
Freezer F2 · box 4 · A1 · −80 °C
301-011-W4-SERSerum · on hold
Try another:
Manifest
M-0412, filed on collection
Handover
14:30 to the courier
Pack
Dry ice · UN3373 checklist complete
301-011-W4-SERSerum · on hold
Try another:
Laboratory
Central laboratory
Analysis
Status recorded per aliquot
Site file
Manifest linked
Expiring supplies, open queries, results awaiting review and temperature excursions, each with an owner and a due date. 4 OPEN
4 open Select an item to mark it actioned. Each keeps its owner and due date.
Reconciliation, supply use, query status and chain of custody for any study. STD-64017
STD-64017 · generated now
Sample reconciliation
412 / 412
Accounted for
7
Not collected, reason recorded
174
Awaiting analysis
Expected412100%
Collected40598%
Processed38994%
Stored27667%
Shipped24860%
Analysed23156%
Stage completeAnalysed · shown against 412 expected
STD-64017 · generated now
Sample reconciliation
412 / 412
Accounted for
7
Not collected, reason recorded
174
Awaiting analysis
Expected412100%
Collected40598%
Processed38994%
Stored27667%
Shipped24860%
Analysed23156%
Stage completeAnalysed · shown against 412 expected
STD-64017 · generated now
Supply use
381412
Used · 38Reserved · 14In stock · 12
0 expired supplies selected
STD-64017 · generated now
Query status
12 raised 11 closed with the sample history attached 1 open · owner L. Patel · due 16 Oct
STD-64017 · generated now
Chain of custody
Collected A. Okafor 09:06 Clinic room 2
Processed J. Reid 09:31 Centrifuge C1
Stored J. Reid 09:58 F2 · box 4 · A1
Packed J. Reid 14:10 Dry ice · UN3373
Courier Handover 14:30 Manifest M-0412
Received Central lab +1 day Receipt logged
Expiring supplies, open queries, results awaiting review and temperature excursions, each with an owner and a due date. 4 OPEN
0 open Select an item to mark it actioned. Each keeps its owner and due date.
Reconciliation, supply use, query status and chain of custody for any study. STD-64017
STD-64017 · generated now
Sample reconciliation
412 / 412
Accounted for
7
Not collected, reason recorded
174
Awaiting analysis
Expected412100%
Collected40598%
Processed38994%
Stored27667%
Shipped24860%
Analysed23156%
Stage completeAnalysed · shown against 412 expected
STD-64017 · generated now
Sample reconciliation
412 / 412
Accounted for
7
Not collected, reason recorded
174
Awaiting analysis
Expected412100%
Collected40598%
Processed38994%
Stored27667%
Shipped24860%
Analysed23156%
Stage completeAnalysed · shown against 412 expected
STD-64017 · generated now
Supply use
381412
Used · 38Reserved · 14In stock · 12
0 expired supplies selected
STD-64017 · generated now
Query status
12 raised 11 closed with the sample history attached 1 open · owner L. Patel · due 16 Oct
STD-64017 · generated now
Chain of custody
Collected A. Okafor 09:06 Clinic room 2
Processed J. Reid 09:31 Centrifuge C1
Stored J. Reid 09:58 F2 · box 4 · A1
Packed J. Reid 14:10 Dry ice · UN3373
Courier Handover 14:30 Manifest M-0412
Received Central lab +1 day Receipt logged

Illustrative views with fictional data.

Where gaps arise

Where does clinical trial sample management break down?

Each study brings its own collection schedule, processing limits and laboratory requirements. When supply logs, handling records and laboratory portals are held separately, outstanding work is difficult to identify and handling is difficult to evidence.

Supply availability and expiry

What happens

Collection supplies arrive in bulk at study start and their expiry dates must be checked against upcoming visits. Shortages or expired supplies can disrupt a planned collection.

When it is identified
Often on the day of the visit

Supply availability and expiry

What happens

Collection supplies arrive in bulk at study start and their expiry dates must be checked against upcoming visits. Shortages or expired supplies can disrupt a planned collection.

When it is identified
Often on the day of the visit

Incomplete processing records

What happens

Collection, processing and storage times recorded after the event make it difficult to confirm that samples met the study’s handling limits.

When it is identified
When the laboratory raises a query

Outstanding laboratory queries

What happens

Queries arriving by email and portal need clear ownership, the sample’s history and timely follow-up while any recollection window remains open.

When it is identified
At reconciliation

Delayed result review

What happens

Safety results from several laboratories need an organised review process, with outstanding assessments visible to the investigators responsible for them.

When it is identified
At the monitoring visit
Operational scope

What does lab sample management software do for a research site?

It turns each sponsor’s lab manual into defined steps at the bench and keeps one record of every sample until it is analysed, stored or destroyed. AQ Labs covers nine workflows across three stages.

01 Before the visit
02 At the bench
03 After the laboratory
At the bench · Workflow 04 of 09

Guided collection and processing.

When the visit opens, staff see the samples due for that participant and timepoint in order of draw, with volumes and handling requirements. Processing timers show the time remaining against the study’s limits, and a missed limit is flagged for assessment and documented follow-up.

Collection · 301-014 · Week 12
Order of draw · Week 12
Serum
K2EDTA · PK
Citrate
Fluoride
Time to freeze38 / 60 min
A missed limit is flagged for assessment
Before the visit · Workflow 01 of 09

Study laboratory set-up.

The sponsor’s lab manual becomes a versioned sample schedule for each visit and timepoint, with laboratories, accreditation certificates and reference ranges on file. When a new manual version is issued, the changes are shown for review before approval.

AQ Assist preparesA draft sample schedule from the lab manual, citing each line to its page. The responsible personChecks every line; a second person approves before use.
Lab manual · new version received
v3v4 · awaiting approval
+Week 16: PD serum added, 2 mL SST
−Week 8: urine sample removed
~PK freeze limit: 90 → 60 minutes
~Shipping: ambient → frozen, dry ice
Changes reviewed before the new version is approved
Before the visit · Workflow 02 of 09

Collection supplies and expiry.

Collection supplies are scanned in with lot and expiry date and reserved against booked visits. Expired supplies are blocked from selection in AQ, and reorder suggestions are based on the visits booked.

AQ Assist preparesA forecast of collection supply needs from booked visits and expiry dates. The responsible personPlaces any order.
Collection supplies · STD-64017
Supplies lot K-2291 · Week 12Expires 30 Nov 2026 In date
Supplies lot K-2104 · Week 16Expires 28 Oct · use first Use first
Supplies lot K-1980 · Week 4Expired 2 Oct Blocked
Reorder suggestion · Week 20Based on 6 booked visits Draft
Expired supplies blocked from selection
Before the visit · Workflow 03 of 09

Visit readiness.

Before each visit, AQ Labs checks that collection supplies are available and in date, that an authorised collector is scheduled and that courier collection is arranged for same-day samples.

Readiness · tomorrow 09:00 visit
Collection supplies available and in datePass
Authorised collector on the rotaPass
Courier collection arranged for same-day samplesPass
All checks passed · recorded against the study
At the bench · Workflow 04 of 09

Guided collection and processing.

When the visit opens, staff see the samples due for that participant and timepoint in order of draw, with volumes and handling requirements. Processing timers show the time remaining against the study’s limits, and a missed limit is flagged for assessment and documented follow-up.

Collection · 301-014 · Week 12
Order of draw · Week 12
Serum
K2EDTA · PK
Citrate
Fluoride
Time to freeze38 / 60 min
A missed limit is flagged for assessment
At the bench · Workflow 05 of 09

Storage and temperature.

Each aliquot is recorded to a freezer, rack, box and position, and storage location records are linked to each sample. When a temperature excursion is recorded, AQ Labs identifies every sample stored in the affected unit so that the sponsor’s decision is documented for each one.

AQ Assist preparesAnswers such as “where is participant 301-014’s Week 12 PK aliquot?” The responsible personSees only what their role and blinding allow.
Storage · scan to position
Freezer F2 · box 4−80 °C
A1 · 301-014-W12-PK1 placed at 09:58
An excursion identifies every sample in the unit
At the bench · Workflow 06 of 09

Shipments and manifests.

Shipments are built by scanning samples, and only samples for the receiving laboratory and storage condition are accepted. Ship-day and stability checks run before packing, a packing checklist reflects the specimen classification and refrigerant, and the manifest is linked to the site file at courier handover.

Shipment · central lab, frozen
Only frozen samples for this laboratory scanned inPass
Ship-day and stability checks passedPass
Packing checklist for specimen class and refrigerantPass
Manifest filed on courier collectionPass
All checks passed · recorded against the study
After the laboratory · Workflow 07 of 09

Laboratory queries.

Each query is linked to the sample it concerns, with an owner, a due date and the sample’s full history. Any recollection is recorded and scheduled in accordance with the protocol and the instructions of the investigator or sponsor.

AQ Assist preparesA draft reply to a laboratory query from the sample’s history. The responsible personEdits and sends the reply.
Lab query · Q-0112
Haemolysed serum · 301-011Owner L. Patel · due 16 Oct Open
Sample history attachedCollection, spin, storage, shipment Linked
RecollectionScheduled per protocol Recorded
Recollection scheduled per protocol
After the laboratory · Workflow 08 of 09

Result review.

Where the study requires investigator review, safety results are presented in one review queue across laboratories. Out-of-range values are highlighted, and the investigator records whether each is clinically significant and signs with re-authentication. AQ Labs does not pre-select the assessment.

AQ Labs does not assess clinical significance, apply signatures or close records.
Results · 301-009 · Week 8
ALT68 U/L7–56CS?
Haemoglobin128 g/L120–160Normal
Potassium6.4 mmol/L3.5–5.3Critical
Creatinine82 µmol/L60–110Normal
Assessment recorded by the investigator
After the laboratory · Workflow 09 of 09

Reconciliation and destruction.

Expected, collected, shipped and analysed samples are reconciled continuously, with a reason recorded for every difference. Destruction is completed under a two-person control in AQ and produces a certificate.

Reconciliation · close-out
412
Expected
405
Collected
248
Shipped
231
Analysed
Signature 1 · J. Reid Signature 2 · S. Malik
Destruction certificate filed
7 not collected · reason recorded for each
A reason recorded for every difference

The sample the schedule expected is the sample the laboratory receives.

01
Scheduled from the lab manual
02
Collected and processed within study limits
03
Shipped with its manifest
04
Reconciled and, where required, reviewed
Authority rests with a person Each requires re-authentication at the moment it is taken. Destruction requires two different people.
Approving asample schedule
Recording clinicalsignificance
Signing aresult review
Releasing a sampleafter an excursion
Destroyinga sample
Connected, not bundled

How does AQ Labs connect to the rest of the study record?

Sample handling depends on the rest of the study: a visit booked within its window, staff trained on the current lab manual, and deviations that reach the quality system. AQ Labs holds the sample record that other AQ modules read, and reads from them in turn. Each module is priced and deployed independently.

AQ Labs
AQ Labs AQ CTMS Hover a module

A visit booked in the study calendar creates that participant’s sample list and timepoints.

Study calendar
Participant 301-014 · Week 12Visit booked · 14 Oct · 08:30Booked
Sample list created
PK plasma, pre-dose4 mL K2EDTA · within 30 min before doseScheduled
Safety bloodsLocal NHS laboratoryScheduled

Illustrative, fictional data.

AQ Labs AQ CTMSHover a module

A visit booked in the study calendar creates that participant’s sample list and timepoints.

Study calendar
Participant 301-014 · Week 12Visit booked · 14 Oct · 08:30Booked
Sample list created
PK plasma, pre-dose4 mL K2EDTA · within 30 min before doseScheduled
Safety bloodsLocal NHS laboratoryScheduled

Illustrative, fictional data.

AQ Labs AQ Digital DoA and AQ QMSHover a module

Recorded delegation and training status determine which staff can perform collection, processing, shipping and review tasks.

Task access · processing
A. Okafor · research nurseDelegated · trained on manual v4Permitted
J. Reid · laboratory technicianDelegated · trained on manual v4Permitted
T. Shah · laboratory technicianTraining on manual v4 outstandingNot permitted

Illustrative, fictional data.

AQ Labs AQ CAPAHover a module

A missed processing limit can be raised as a deviation and, where needed, a corrective action.

Processing record
301-011-W4-SERCollected 10:12 · stored 11:16 · 64 of 60 minLimit missed
Deviation DEV-031Raised from the sample recordRaised
Corrective actionWhere needed, owner assignedIf needed

Illustrative, fictional data.

AQ Labs AQ eISF and eTMFHover a module

Laboratory certificates, reference ranges, manifests and signed reviews are linked to the site file, with filing and access determined by record type.

Linked to the site file
Laboratory accreditation certificateCentral laboratory · 2026Linked
Reference rangesLocal NHS laboratory · v3Linked
Shipment manifest M-0412Frozen · central laboratoryLinked
Signed result reviewParticipant 301-014 · Week 12Linked

Illustrative, fictional data.

AQ Labs AQ PharmacyHover a module

Dosing and sampling are held on the same record, so PK sampling times can be read against the recorded dose time.

Dose and sampling · Week 12
08:20 window08:31 PK sample08:50 dose
Dose recorded08:50 · read from the pharmacy recordRecorded
PK sample19 minutes before the recorded doseWithin window

Illustrative, fictional data.

Works alongside systems already in use Adopt AQ Labs on its own, or extend the same governance across the rest of AQ Platform.
Central-laboratory portals
Hospital laboratory systems
Couriers
Temperature monitoring systems
Guide · AQ Labs module guide
Collection supplies, processing, storage, shipping and result review in one controlled record.
Download the guide
One record, five roles

What changes for the people who handle samples?

Today

Study-specific worklists prepared from each lab manual, with collection times recorded on requisition forms.

With AQ Labs

Samples due appear when the visit opens, in order of draw, with collection times recorded at the bedside.

Today

Study-specific worklists prepared from each lab manual, with collection times recorded on requisition forms.

With AQ Labs

Samples due appear when the visit opens, in order of draw, with collection times recorded at the bedside.

Today

Processing limits tracked manually and storage positions held in separate freezer maps.

With AQ Labs

Processing timers show remaining time against study limits, and every storage position is recorded by scan.

Today

Supply logs, shipment trackers and query correspondence maintained separately for each study.

With AQ Labs

One view of supplies, shipments and open queries across every study.

Today

Safety reports reviewed across several laboratory systems, with outstanding reviews tracked separately.

With AQ Labs

One review queue across laboratories, with each assessment signed and linked to the participant’s record.

Today

Sample history assembled from logs, portals and correspondence when requested.

With AQ Labs

Read-only access to current sample history, queries and manifests.

Alongside what you already run

How does AQ Labs work with laboratory portals and hospital systems?

AQ Labs does not replace the systems laboratories and hospitals use. It gives the site one record of its own sample activity across all of them.

Central-laboratory portal
What it does

Laboratory-specific ordering, queries and results for one laboratory

What AQ Labs adds for the site

Every laboratory’s samples, shipments and queries on one site record

Hospital laboratory system
What it does

Local diagnostic requests and results

What AQ Labs adds for the site

Trial safety samples tracked alongside research samples, with investigator review recorded

Temperature monitoring system
What it does

Temperature readings and alarms

What AQ Labs adds for the site

Excursions linked to the samples stored in the affected unit, with decisions recorded per sample

Spreadsheets and paper logs
What it does

Locally maintained supply, processing and storage records

What AQ Labs adds for the site

Records captured as work happens, with an audit trail and links to delegation, training and the site file

Built on assured foundations NHS DSPT Standards Met 2026Cyber Essentials21 CFR Part 11 electronic signaturesUK-hosted
Questions

Questions sites ask about AQ Labs.

AQ Labs is the lab sample management module of AQ Platform. It records every sample a trial sends to a laboratory, from the sponsor’s lab manual through collection supplies, collection, processing, storage, shipment and queries to result review where the study requires it, on the same record as the site file.

Many sites combine central-laboratory portals, spreadsheets and paper logs. AQ Labs brings sample activity from every study and laboratory into one site record, linked to delegation, training and the site file.

AQ Platform does. AQ Labs runs on the same record as AQ eISF, so laboratory certificates, reference ranges, manifests and signed result reviews are linked to the site file as work is completed.

In AQ Labs, collection supplies are scanned in with lot and expiry date and reserved against booked visits. Supplies close to expiry are flagged for use first, expired supplies are blocked from selection, and reorder suggestions are based on the visits booked.

Each handling step is recorded with the person, the event time and the location: collection, processing, storage and moves, packing, courier handover and laboratory receipt. The audit history is retained and exportable in line with the agreed retention requirements.

Where the study requires investigator review, safety results appear in one review queue. Out-of-range values are highlighted, and the investigator records whether each is clinically significant, adds comments where needed and signs with re-authentication. AQ Labs does not pre-select the assessment.

Shipments are built by scan, and only samples for the receiving laboratory and storage condition are accepted. Ship-day and stability checks run before packing, and the packing checklist reflects the specimen classification, such as UN3373 for Category B biological substances, and the refrigerant, such as dry ice. The manifest is linked to the site file at courier handover.

When an excursion is recorded for a storage unit, AQ Labs identifies every sample stored in it and places them on hold. The sponsor’s decision is recorded for each sample before it can be shipped or used.

No. Central laboratories keep their own systems for ordering, analysis and results. AQ Labs is the site’s own record of sample activity across every laboratory it works with.

Yes. Safety samples sent to the hospital laboratory are tracked alongside central-laboratory samples. Local requests follow the receiving laboratory’s identification requirements, while research shipments use the identifiers specified for the study, with access to identifiable information restricted by role.

The withdrawal and its scope are recorded, and every affected sample is identified wherever it is held. Further collection stops, and decisions on stored samples are recorded in line with the consent given, the protocol and the Human Tissue Act where it applies. Samples already analysed cannot be withdrawn. Destruction, where decided, is completed under AQ’s two-person control and produces a certificate.

AQ Labs is built for UK and NHS research sites. It tracks local NHS laboratory samples alongside central-laboratory samples, records consent and retention decisions with reference to the Human Tissue Act, and runs on UK-hosted AQ Platform, which meets the NHS DSPT standard.

Yes. AQ Labs is priced and deployed as its own module, and other AQ modules can be added later. Used together, the modules share one governed record.

Yes, under human control. AQ Assist prepares draft schedules, supply forecasts and query replies for staff to review. Every suggestion and decision is recorded in the audit trail, and AI does not assess clinical significance, apply signatures or close records.

Not covered here? Write to enquiries@aq-trials.com.

Take control

Request a live AQ Platform
demonstration.

Thirty minutes on your own studies: samples, collection supplies, shipments and results, and how AQ Labs connects to your site file, delegation log and pharmacy. AQ Labs is priced and deployed as its own module, and every conversation starts with a free first consultation.

BOOK A DEMO
Request a Guided AQ Tour

Practical walkthroughs aligned with active research delivery.

We’ll only use your details to arrange your demo and
send relevant AQ updates. No spam.

AQUsed only to arrange your demo. No spam, no third parties.REPLY WITHIN ONE WORKING DAY
01The modules that match your study operations
02A real workflow, end to end, with the audit trail
03Onboarding, configuration and your timeline
21 CFR PART 11ICH-GCPDSPTCYBER ESSENTIALSG-CLOUD
Free guides · PDF
Find the right guide for you

Pick a module, your organisation type, or both — we'll match the guides and email them to you.

Most popular guides
Explore
15+ guides
Free guides · PDF
Guides matched to you.

✓ Written for first-in-human & Phase 1 sites

✓ Inspection-ready checklists & templates

✓ Aligned to MHRA, FDA & EU Annex 11